Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genzyme, Isis Retool Mipomersen Deal

Jun 24 2008

• By Randall Osborne

Related Content

Genzyme, Isis Partner On Lipid Lowering Treatment Based On Antisense Technology

Jan 07 2008

Genzyme/Isis’ Mipomersen Development Outlook Pricier And Riskier After FDA Weighs In

Apr 25 2008

Genzyme/Bayer Hope To Fly With Single Campath Phase III Trial In MS

Apr 23 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window